Document is current
Any future updates will be listed below
-
Authors
,
Anckaert, Jasper
Avila Cobos, Francisco
Decock, Anneleen
Decruyenaere, Philippe
Deleu, Jill
De Preter, Katleen
De Wever, Olivier
De Wilde, Jilke
Dhondt, Bert
D’huyvetter, Thibaut
Everaert, Celine
Fierro, Carolina
Helsmoortel, Hetty H.
Hendrix, An
Hulstaert, Eva
Koster, Jan
Kuersten, Scott
Mercer, Tim R.
Mestdagh, Pieter
Morlion, Annelien
Nijs, Nele
Nuytens, Justine
Philippron, Annouck
Piofczyk, Thomas
Poma-Soto, Franco
Schoofs, Kathleen
Schroth, Gary P.
Thas, Olivier
Vanden Eynde, Eveline
Vandesompele, Jo
Van Maerken, Tom
Van Paemel, Ruben
Verniers, Kimberly
Verwilt, Jasper
Yigit, Nurten
- License Information
-
More Information
Article History
Received: 13 January 2023
Accepted: 24 March 2025
First Online: 15 May 2025
Competing interests
: C.F. is an employee, N.N. and T.P. are former employees, P.M. is a consultant, and J.Va is a co-founder of Biogazelle, a clinical CRO providing human biofluid extracellular RNA sequencing, now a CellCarta company. G.P.S. is a former employee and S.K. is an employee of Illumina, providing library preparation and sequencing reagents. The remaining authors declare no competing interests. Promega, Qiagen and Roche sponsored blood collection tubes and/or RNA purification methods. Funders did not influence data analysis, interpretation, and manuscript writing.
